Aptevo Therapeutics
APVO
APVO
27 hedge funds and large institutions have $2.64M invested in Aptevo Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Barclays
London,
United Kingdom
|
$0 |
2 |
V
2
Veritable
Wilmington,
Delaware
|
$0 |
3 |
3
Morgan Stanley
New York
|
$57K |
4 |
4
Renaissance Technologies
New York
|
$208K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$1K |